echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Merck's new crown specific drug final data is lower than estimated Pfizer decides to increase Paxlovid production capacity

    Merck's new crown specific drug final data is lower than estimated Pfizer decides to increase Paxlovid production capacity

    • Last Update: 2022-01-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    CompilationTom Lee

    Pfizer CEO Albert Bourla said in an interview with CNBC television in the US on Monday that Pfizer now expects to produce 80 million courses of the COVID drug Paxlovid by the end of 2022


    External analysis believes that an important reason for Pfizer's decision to increase production capacity is the failure of competitors' trials


    The less-than-expected test results stimulated expectations of increased demand for Paxlovid, which showed that the risk for outpatients was reduced by 89%


    The emergence of the new coronavirus variant omicron has once again raised concerns about the power of existing vaccines and therapies


    The SARS-CoV-2 coronavirus uses the spike protein on its surface to infect healthy cells, and Paxlovid is a protease inhibitor designed to block the enzymes required for virus replication


    However, the premise of all these expectations is that Pfizer Paxlovid's efficacy data are true and reliable


    Reference source:

    1.


    2.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.